PDL BioPharma, Inc. Issuance/Purchase of Shares

Issuance/Purchase of Shares of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Issuance/Purchase of Shares growth rates and interactive chart.


Highlights and Quick Summary

  • Issuance/Purchase of Shares for the quarter ending June 29, 2020 was $-19.7 Million (a 2.4% increase compared to previous quarter)
  • Year-over-year quarterly Issuance/Purchase of Shares increased by 325.66%
  • Annual Issuance/Purchase of Shares for 2019 was $-86.9 Million (a 76.95% increase from previous year)
  • Annual Issuance/Purchase of Shares for 2018 was $-49.1 Million (a 63.7% increase from previous year)
  • Annual Issuance/Purchase of Shares for 2017 was $-30 Million (a -120.04% decrease from previous year)
  • Twelve month Issuance/Purchase of Shares ending June 29, 2020 was $-54.5 Million (a -11.79% decrease compared to previous quarter)
  • Twelve month trailing Issuance/Purchase of Shares decreased by -45.46% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-54.5 Million $-61.8 Million $-86.9 Million $-100 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Issuance/Purchase of Shares of PDL BioPharma, Inc.

Most recent Issuance/Purchase of Sharesof PDLI including historical data for past 10 years.

Interactive Chart of Issuance/Purchase of Shares of PDL BioPharma, Inc.

PDL BioPharma, Inc. Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-19.69 $-19.23
2019 $-11.01 $-4.63 $-26.98 $-44.29 $-86.9
2018 $-24.11 $-1.4 $-20.04 $-3.56 $-49.11
2017 $0.0 $0.0 $-22.35 $-7.65 $-30.0
2014 $0.0 $11.43
2011 $149.71 $149.71

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.